Iterum Therapeutics plc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Iterum Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Iterum Therapeutics plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $7.22M, a 2971% increase year-over-year.
  • Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.03M.
  • Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.82M, a 102% decline from 2021.
  • Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $83.1M, a 28.9% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.03M +$2.85M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$1.82M -$84.9M -102% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $83.1M +$18.7M +28.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $64.5M +$62.4M +3025% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $2.06M -$120M -98.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-28
2018 $122M +$76.3M +166% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $45.9M +$25M +120% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $20.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.